Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.

U Brandl, M Erhardt, H Joeckle, S Michel, P Brenner, I Bittmann, M Roessle, Volker Mordstein (Co-author), C Hammer, M Schmoeckel, B Reichart

    Research output: Contribution to journalEditorialpeer-review

    2 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)491-492
    JournalTRANSPLANTATION PROCEEDINGS
    Volume37
    Issue number1
    DOIs
    Publication statusPublished - 2005

    Keywords

    • XENOGRAFT REJECTION

    Cite this